Will the real heart-healthy diet please stand up! Joseph S. Alpert Editor’s Commentary Pages: 335 - 336
Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes Eric R. Bates OriginalPaper Pages: 348 - 354
Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: Initiate treatment early or wait for the catheterization laboratory? David J. HarnickDavid A. Vorchheimer OriginalPaper Pages: 355 - 361
Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Kenneth W. Mahaffey OriginalPaper Pages: 362 - 370
Complications of oral antiplatelet medications Eric Van De GraaffSteven R. Steinhubl OriginalPaper Pages: 371 - 379
The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events Angelo M. Scanu News Pages: 385 - 390
The optimal dietary strategy to manage risk associated with various dyslipidemias Neil J. Stone OriginalPaper Pages: 391 - 400
Treatment of dyslipidemia in pre- and postmenopausal women with and without known atherosclerotic cardiovascular disease Vera Bittner OriginalPaper Pages: 401 - 407
Potential use of Ca++ scanning to determine the need for and intensity of lipid-lowering therapy in asymptomatic adults Alan D. GuerciYadon Arad OriginalPaper Pages: 408 - 415
Pathophysiology and treatment of the dyslipidemia of insulin resistance Gregory CohnGerardo ValdesDavid M. Capuzzi OriginalPaper Pages: 416 - 423
Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit Dennis L. Sprecher OriginalPaper Pages: 424 - 432
